Commentary
Methylprednisolone for acute spinal cord injury: not a standard of care
Herman Hugenholtz
History
- Published online April 29, 2003.
Author Information
- Herman Hugenholtz
- Dr. Hugenholtz is with the Division of Neurosurgery, Queen Elizabeth II Health Sciences Centre, Halifax, NS.Members of the Committee of the Canadian Spine Society and the Canadian Neurosurgical Society to Review the Role of Methylprednisolone in Acute Spinal Cord Injury:
Herman Hugenholtz (chair), Division of Neurosurgery, Queen Elizabeth II Health Sciences Centre, Halifax, NS; Nirmala D. Bharatwal, Toronto Rehabilitation Institute, Toronto, Ont.; Dan E. Cass, Director of Emergency Services, St. Michael's Hospital, Toronto, Ont.; Marcel F. Dvorak, Medical Director, Combined Spine Program, Vancouver Hospital and Health Sciences Centre, Vancouver, BC; Derek Fewer, Section of Neurosurgery, Health Sciences Centre, Winnipeg, Man.; Richard J. Fox, Department of Neurosurgery, Walter C. Mackenzie Health Science Centre, University Hospital, Edmonton, Alta.; Dennis M.S. Izukawa, Department of Neurosurgery, Trillium Health Centre, Mississauga, Ont.; Joel Lexchin, Emergency Department, University Health Network, Toronto, Ont.; Christine Short, Nova Scotia Rehabilitation Centre, Halifax, NS; and Sagun Tuli, Department of Neurosurgery, Brigham and Women's Hospital, Boston, Mass.
- Correspondence to:
Dr. Herman Hugenholtz, New Halifax Infirmary, Rm. 3808, 1796 Summer St., Halifax NS B3H 3A7; fax 902 473-8912
Statistics from Altmetric.com